International Cellular Medicine Society
Nonprofit profile at a glance
- EIN
- 752985553
- IRS 990-EZ coverage
- 2011–2024
- Forms available
- Form 990-EZ 2024, Form 990-N 2009
- Location
- Las Vegas, NV, USA
- Phone
- 7026640017
- Rating
- 84
- Verdict
- STRONG
- Rating confidence
- Moderate
- Sector
- Nerve, Muscle, Bone Diseases Research
Reported finances
- Revenue
- $30,371
- Expenses
- $30,031
- Assets
- $1,041
- Liabilities
- $0
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
4 people listed
Executive titles in this filing
- REED DAVIS (EXECUTIVE DIRECTOR)
People named in this filing
- REED DAVIS (EXECUTIVE DIRECTOR)
- SEAN KOHLES PHD (DIRECTOR)
- NICHOLAS L'HEUREUX PHD (DIRECTOR)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
To provide education, oversight, and best practices to assure patient safety, ethical conduct, and effective treatment; to build a comprehensive registry of adult stem cell procedures and prove 20 year tracking of patient outcomes and complications; to provide clinical and lab guidelines to assure that physicians and clinics worldwide are using best practices to collect process and re-implant adult stem cells in patients; and to provide an international institutional review board to classify, monitor, and advance safe effective cell lines and procedures.
What it reported doing in 2024
Expansion of the icms institutional review board to provide a thorough evaluation of adult stem cell-based protocols and studies. Protocol safety and efficacy is the primary focus with an emphasis on study design, patient inclusion and exclusion criteria, collection of data and tracking patient outcomes. Additionally, the enhancement of the icms clinical and laboratory accreditation program to assure that physicians and laboratories are using best practices for the collection, processing and re-implantation of adult stem cells.
Operating model
- Revenue model
- Earned-program. 100% of the money available for current operations came from fees and other program revenue.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
STRONG - A large share of available resources goes toward mission work and the filed numbers largely add up. Program spending has declined or grown slowly and revenue has declined or grown slowly.
Rating breakdown
- Financial Efficiency: 99
- Transparency & Controls: 82
- Sustainability: 39
- Growth: 0
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 98.9%; rating input score 99
- Program expense ratio: 100%; rating input score 100
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
- Major donor itemization: Limited
Sustainability
- Operating margin: 1.1%; rating input score 48; 48th percentile among comparable filings
- Total-asset coverage ratio: 0.03; rating input score 7; 7th percentile among comparable filings
- Liabilities to assets ratio: 0; rating input score 68; 68th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 56; 56th percentile among comparable filings
Growth
- Program expense growth: -9.7% per year; rating input score 0; 28th percentile among comparable filings
- Revenue growth: -8.9% per year; rating input score 0; 26th percentile among comparable filings
- Asset growth: -24.3% per year; rating input score 0; 8th percentile among comparable filings
Details
- Where the money goes: 98.9% of revenue deployed · 100% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment · $30K in reported program spending
- Leadership: top reported pay $0 · 4 people listed
- Consistency: 8 of 8 current checks pass
- Schedules: 2 filed schedules
- Filing history: 13 filing years from 2011 to 2024
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Growth: Program expense growth scored 0/100.
- High — Growth: Revenue growth scored 0/100.
- High — Sustainability: Total-asset coverage ratio scored 7/100.
- Moderate — Sustainability: Operating margin scored 48/100.
- High — Growth: Asset growth scored 0/100.
- Review — Sustainability: Officer compensation ratio scored 56/100.